UC AKT.ANL. 03/25 SAX/ DE000HD46Q97 /
2024-05-08 11:46:16 AM | Chg.+0.080 | Bid12:21:49 PM | Ask12:21:49 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
103.830EUR | +0.08% | 104.050 Bid Size: 125,000 |
104.210 Ask Size: 125,000 |
STROEER SE + CO. KGA... | 54.00 - | 2025-03-28 | Call |
GlobeNewswire
12:45 PM
Compass Pathways Announces First Quarter 2024 Financial Results and Business Highlights
GlobeNewswire
12:40 PM
Cellectar Biosciences to Present at the Guggenheim Healthcare Talks Radiopharmaceuticals Day
GlobeNewswire
12:36 PM
Temenos Multifonds extends partnership with Citi Securities Services to consolidate global funds ser...
GlobeNewswire
12:30 PM
Veru Reports Fiscal 2024 Second Quarter Financial Results and Progress of its Enobosarm High Quality...
GlobeNewswire
12:30 PM
Beam Therapeutics to Participate in RBC Capital Markets 2024 Global Healthcare Conference
GlobeNewswire
12:30 PM
Compass Pathways announces durable improvement in symptoms through 12 weeks in open-label phase 2 st...
GlobeNewswire
12:15 PM
Taboola Q1 2024 Results Beat High End of Guidance; Reiterates 2024 Guidance and Expects Accelerating...
GlobeNewswire
12:00 PM
Latest DB-OTO Results Show Dramatically Improved Hearing to Normal Levels in a Child with Profound G...